Method and system for buoyant-particle-assisted cell therapy
AssigneeAkadeum Life Sciences, Inc.
InventorsTiffany Snow, Jonathan Roussey, Casey Wegner, Brandon H. McNaughton
Life of this patent
Estimating the term…
Abstract
A system for buoyant-particle-assisted cell therapy includes and/or interfaces with a set of buoyant particles. Additionally or alternatively, the system can include and/or interface with a processing container, a set of processing materials (e.g., buffers, factors, solutions, etc.), and/or any other components. A method for buoyant-particle-assisted cell therapy includes processing the set of cells of interest. Additionally or alternatively, the method can include any or all of: preparing a set of buoyant particles; receiving a sample; and isolating a set of cells of interest from the sample.
Claims7
A method for buoyancy-assisted production of cells for a cell therapy, the method comprising:
- initiating a 1st selection process, the 1st selection process comprising:
- combining T cells and a 1st set of buoyant particles, wherein the 1st set of buoyant particles are functionalized with moieties for binding to and forming a complex with the T cells to produce first bound T cells;
- and
- initiating a cell activation and expansion process comprising a 2nd selection process, the cell activation and expansion process comprising:
- producing second bound T cells by combining a set of activators factors, a 2nd set of buoyant particles, and the T cells within a container, wherein the set of activation factors are antibodies, wherein the 2nd set of buoyant particles are functionalized with moieties for binding to and forming a complex with the antibodies, wherein in at least a portion of the second bound T cells, a single T cell is bound to multiple buoyant particles of the 2nd set of buoyant particles, wherein the second bound T cells aggregate at a superior region of the container;
- culturing the second bound T cells in the container to produce daughter cells from the second bound T cells;
- increasing a spatial separation of the daughter cells relative to the second bound T cells, thereby preventing exhaustion of the daughter cells due to exposure of the daughter cells to the antibodies, wherein the daughter cells aggregate at an inferior surface of the container;
- and
- collecting the daughter cells, wherein the daughter cells are used in the cell therapy.
Dependencies are inferred from the claim text.